Single-dose anti-CD138 radioimmunotherapy: bismuth-213 is more efficient than lutetium-177 for treatment of multiple myeloma in a preclinical model

by Nolwenn eFichou, Nolwenn eFichou, Nolwenn eFichou, Sébastien eGouard, Sébastien eGouard, Sébastien eGouard, Catherine eMaurel, Catherine eMaurel, Catherine eMaurel, Jacques eBarbet, Jacques eBarbet, Jacques eBarbet, Ludovic eFerrer, Ludovic eFerrer, Ludovic eFerrer, Ludovic eFerrer, Alfred eMorgenstern, Frank eBruchertseifer, Alain eFaivre-Chauvet, Alain eFaivre-Chauvet, Alain eFaivre-Chauvet, Alain eFaivre-Chauvet, Edith eBigot-Corbel, Edith eBigot-Corbel, Edith eBigot-Corbel, François eDavodeau, François eDavodeau, François eDavodeau, Joelle eGaschet, Joelle eGaschet, Joelle eGaschet, Michel eChérel, Michel eChérel, Michel eChérel, Michel eChérel
Published 2015-11-01